cambridge's bluebird bio licenses delivery tech to novartis, gsk..

stephen silberstein, md, director, jefferson university headache center..

it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say.

the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid...

.